Related Experiment Video
Updated: Mar 14, 2026
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes
Feng Yue1,2, Sien Zeng3, Rongping Tang4
1Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
Abstract:
In this study, we developed a systemic PD model in middle-aged cynomolgus monkeys using individualized low-dose MPTP, to explore effective indicators for the early prediction of clinical outcomes. MPTP was not stopped until the animals showed typical PD motor symptoms on days 10 to 13 after MPTP administration when the Kurlan score reached 10; this abrogated the differences in individual susceptibility to MPTP. The clinical symptoms persisted, peaking on days 3 to 12 after MPTP withdrawal (rapid progress stage), and then the Kurlan score plateaued. A Kurlan score at the end of the rapid progress stage >15 reflected stable or slowly-progressive PD, while a score <15 indicated spontaneous recovery. The entire clinical evolution and outcome of the systemic PD model was characterized in this study, thus providing options for therapeutic and translational research.
Insights
This study established a Parkinson disease (PD) model in monkeys using MPTP, identifying early indicators to predict clinical outcomes and recovery. The Kurlan score effectively differentiates between stable PD and spontaneous recovery in this novel preclinical model.
Area of Science:
- Neuroscience
- Pharmacology
- Primate Models
Background:
- Parkinson disease (PD) modeling is crucial for therapeutic development.
- Existing models often lack consistency in disease progression and individual responses.
- A reliable preclinical model is needed to predict clinical outcomes and guide translational research.
Purpose of the Study:
- To develop a reproducible systemic Parkinson disease (PD) model in cynomolgus monkeys.
- To identify early predictive indicators for clinical outcomes in this PD model.
- To characterize the clinical evolution and recovery patterns for translational research.
Main Methods:
- Administered individualized low-dose MPTP to middle-aged cynomolgus monkeys.
- Monitored motor symptoms using the Kurlan score until typical PD symptoms appeared.
- Analyzed Kurlan scores during the rapid progress stage post-MPTP withdrawal to predict outcomes.
Main Results:
- MPTP administration induced consistent PD motor symptoms, with Kurlan scores reaching 10 by days 10-13.
- A Kurlan score >15 at the end of the rapid progress stage indicated stable or slowly progressive PD.
- A Kurlan score <15 predicted spontaneous recovery from PD symptoms.
Conclusions:
- The developed MPTP-induced PD model in monkeys offers a standardized approach for preclinical studies.
- The Kurlan score serves as an effective early indicator for predicting PD progression and recovery.
- This model provides a valuable platform for testing therapeutic interventions and advancing PD research.
